As NF-κB is crucial for transcription of inflammatory cytokines associated with severe COVID-19 [109], further trials are needed to elucidate whether selenium supplementation can downregulate NF-κB expression in vivo and indeed whether this confers a survival benefit. The gene discussed is NFKB1; the disease is COVID-19.